Samuel Kintz - Net Worth and Insider Trading
Samuel Kintz Net Worth
The estimated net worth of Samuel Kintz is at least $28 Million dollars as of 2024-11-05. Samuel Kintz is the PRESIDENT AND CEO of Enliven Therapeutics Inc and owns about 1,002,892 shares of Enliven Therapeutics Inc (ELVN) stock worth over $28 Million. Details can be seen in Samuel Kintz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel Kintz has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel Kintz
Samuel Kintz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Kintz owns 1 companies in total, including Enliven Therapeutics Inc (ELVN) .
Click here to see the complete history of Samuel Kintz’s form 4 insider trades.
Insider Ownership Summary of Samuel Kintz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | director & President and CEO |
Samuel Kintz Latest Holdings Summary
Samuel Kintz currently owns a total of 1 stock. Samuel Kintz owns 1,002,892 shares of Enliven Therapeutics Inc (ELVN) as of October 18, 2024, with a value of $28 Million.
Latest Holdings of Samuel Kintz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | 1,002,892 | 27.72 | 27,800,166 |
Holding Weightings of Samuel Kintz
Samuel Kintz Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel Kintz has made a total of 19 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 924 shares on October 18, 2024, which brought Samuel Kintz around $27,720.
Insider Trading History of Samuel Kintz
- 1
Samuel Kintz Trading Performance
Samuel Kintz Ownership Network
Ownership Network List of Samuel Kintz
Ownership Network Relation of Samuel Kintz
Samuel Kintz Owned Company Details
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Samuel Kintz is the director & President and CEO of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Financial Officer Benjamin Hohl , Chief Operating Officer Anish Patel , and director & Chief Scientific Officer Joseph P Lyssikatos .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Samuel Kintz made 19 insider transaction in Enliven Therapeutics Inc (ELVN) with a net sale of 240,342. Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 239,847 shares made by Joseph P Lyssikatos , a net sale of 88,314 shares made by Benjamin Hohl , and a net sale of 30,154 shares made by Richard A. Heyman .
In summary, during the past 3 months, insiders sold 183,359 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 183,359 shares. During the past 18 months, 4,855,709 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,855,709 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
Samuel Kintz Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Kintz. You might contact Samuel Kintz via mailing address: Enliven Therapeutics Inc, 6200 Lookout Road, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
